Male Urogenital Diseases

160 trials 69 recruiting

Filter these 160 trials by phase, country and sponsor.

Open in Search →

A study to see how well PLS240 works in treating secondary hyperparathyroidism, and how safe it is, in end stage kidney disease participants… Ended

2023-504339-41-00 ESKD participants with history of secondary hyperparath 5 2023-11-08
A Single Dose, Fed state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (Iasis Pharma) vs. FU… Ended

2023-503887-18-00 healthy subjects 2 2023-10-02
A double-blind, randomized, placebo-controlled, dose-escalating Phase I trial to determine the safety, pharmacokinetic parameters, and clini… Ended

2023-504671-24-00 Men and women infertility 1 2023-09-22
A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PARALLEL AND PLACEBO-CONTROLLED SINGLE AND MULTIPLE ASCENDING DOSE TRIAL INVESTIGATING SAFETY, TOLERAB… Ended

2023-505280-36-00 Erectile dysfunction 1 2023-08-25
DapaBalci-Leap Ended

2024-516032-10-00 Stage 3 chronic kidney disease 4 2023-07-13
Overactive Bladder Treatment with Xeomin and Vibe Delivery System (XAVIER) Ended

2022-501759-95-00 Overactive bladder (OAB) 4 2023-06-05
A trial to compare efficacy and safety of follitropin delta versus placebo (inactive treatment) in the treatment of men with idiopathic infe… Ended

2023-508430-34-00 Idiopathic male infertility (including oligoasthenozoos 4 2023-01-12
VISIONARY Trial: Phase 3 Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) Ended

2022-500079-30-00 IgA Nephropathy 5 2022-11-03
A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis Ended

2024-511706-23-00 Focal segmental glomerulosclerosis 4 2022-05-31
The implementation of imaging guidance in surgery for patients with prostate cancer who are candidate to undergo robot-assisted prostatectom… Ended

2024-514583-12-00 Patients with prostate cancer (PCa) who are candidate t 4 2021-05-05
Lutetium-177-PSMA in Oligo-metastatic Hormone Sensitive Prostate Cancer. Ended

2023-509881-39-00 prostate cancer 4 2020-07-27
CONDYVAC. Efficacy study of the quadrivalent Human Papilloma Virus (HPV) vaccine to prevent recurrence of External Genital Warts (EGW) in pa… Ended

2024-516098-62-00 External Genital Warts (EGW) 5 2018-01-11
A study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in patients affected by high-risk prostate cancer Ended

2024-514580-26-00 High-risk prostate cancer 4
Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Ended

2024-512754-16-01 Prostate cancer 5
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pr… Ended

2024-516319-25-00 Prostate Cancer 4
IMPACT OF LEVOTHYROXINE ON ERECTILE FUNCTION IN PATIENTS WITH HYPOTHYROIDISM Ended

2024-514789-38-00 erectile function 6